Carlson College of Veterinary Medicine

J. A. Maddry, Bansal, N., Bermudez, L. E., Comber, R. N., Orme, I. M., Suling, W. J., Wilson, L. N., and Reynolds, R. C., “Homologated aza analogs of arabinose as antimycobacterial agents.”, Bioorganic & medicinal chemistry letters, vol. 8, no. 3, pp. 237-42, 1998.

C. A. Kemper, Bermudez, L. E., and Deresinski, S. C., “Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor.”, The Journal of infectious diseases, vol. 177, no. 4, pp. 914-20, 1998.

S. Y. Kim, Goodman, J. R., Petrofsky, M., and Bermudez, L. E., “Mycobacterium avium infection of gut mucosa in mice associated with late inflammatory response and intestinal cell necrosis.”, Journal of medical microbiology, vol. 47, no. 8, pp. 725-31, 1998.

L. E. Bermudez, Petrofsky, M., and Stevens, P., “Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.”, Immunology, vol. 94, no. 3, pp. 297-303, 1998.

L. E. Bermudez and Inderlied, C. B., “Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages.”, Microbial drug resistance (Larchmont, N.Y.), vol. 3, no. 3, pp. 277-82, 1997.

L. E. Bermudez, Petrofsky, M., and Goodman, J., “Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells.”, Infection and immunity, vol. 65, no. 9, pp. 3768-73, 1997.

A. E. Parker and Bermudez, L. E., “Expression of the green fluorescent protein (GFP) in mycobacterium avium as a tool to study the interaction between Mycobacteria and host cells.”, Microbial pathogenesis, vol. 22, no. 4, pp. 193-8, 1997.

L. E. Bermudez, Parker, A., and Goodman, J. R., “Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway.”, Infection and immunity, vol. 65, no. 5, pp. 1916-25, 1997.

J. D. Cirillo, Falkow, S., Tompkins, L. S., and Bermudez, L. E., “Interaction of Mycobacterium avium with environmental amoebae enhances virulence.”, Infection and immunity, vol. 65, no. 9, pp. 3759-67, 1997.

N. Azouaou, Petrofsky, M., Young, L. S., and Bermudez, L. E., “Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.”, Immunology, vol. 91, no. 3, pp. 414-20, 1997.

N. Mohagheghpour, Gammon, D., van Vollenhoven, A., Hornig, Y., Bermudez, L. E., and Young, L. S., “Mycobacterium avium reduces expression of costimulatory/adhesion molecules by human monocytes.”, Cellular immunology, vol. 176, no. 1, pp. 82-91, 1997.

L. E. Bermudez and Petrofsky, M., “Regulation of the expression of Mycobacterium avium complex proteins differs according to the environment within host cells.”, Immunology and cell biology, vol. 75, no. 1, pp. 35-40, 1997.

L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Barbara-Burnham, L., and Young, L. S., “Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.”, Antimicrobial agents and chemotherapy, vol. 40, no. 3, pp. 546-51, 1996.

T. Tojimbara, Bermudez, L. E., Egawa, H., Hayashi, M., So, S. K., and Esquivel, C. O., “Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro.”, Transplantation proceedings, vol. 28, no. 3, pp. 1381-2, 1996.

L. E. Bermudez, Nash, K. A., Petrofsky, M., Young, L. S., and Inderlied, C. B., “Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.”, The Journal of infectious diseases, vol. 174, no. 6, pp. 1218-22, 1996.

L. E. Bermudez, Petrofsky, M., and Shelton, K., “Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection.”, Infection and immunity, vol. 64, no. 8, pp. 2917-22, 1996.

T. Tantawichien, Young, L. S., and Bermudez, L. E., “Interleukin-7 induces anti-Mycobacterium avium activity in human monocyte-derived macrophages.”, The Journal of infectious diseases, vol. 174, no. 3, pp. 574-82, 1996.

L. E. Bermudez and Goodman, J., “Mycobacterium tuberculosis invades and replicates within type II alveolar cells.”, Infection and immunity, vol. 64, no. 4, pp. 1400-6, 1996.

L. E. Bermudez, Kolonoski, P., and Young, L. S., “Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.”, Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.

L. E. Bermudez, Shelton, K., and Young, L. S., “Comparison of the ability of Mycobacterium avium, M. smegmatis and M. tuberculosis to invade and replicate within HEp-2 epithelial cells.”, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 76, no. 3, pp. 240-7, 1995.

L. E. Bermudez, Petrofsky, M., Inderlied, C. B., and Young, L. S., “Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice.”, The Journal of antimicrobial chemotherapy, vol. 36, no. 4, pp. 641-6, 1995.

L. E. Bermudez, Wu, M., and Young, L. S., “Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.”, Infection and immunity, vol. 63, no. 10, pp. 4099-104, 1995.

E. M. Foley-Thomas, Whipple, D. L., Bermudez, L. E., and Barletta, R. G., “Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis.”, Microbiology (Reading, England), vol. 141 ( Pt 5), pp. 1173-81, 1995.

J. Champsi, Young, L. S., and Bermudez, L. E., “Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.”, Immunology, vol. 84, no. 4, pp. 549-54, 1995.

L. E. Bermudez and Kaplan, G., “Recombinant cytokines for controlling mycobacterial infections.”, Trends in microbiology, vol. 3, no. 1, pp. 22-7, 1995.